Multiplexed Electrochemical Cancer Diagnostics With Automated Microfluidics.
暂无分享,去创建一个
James F. Rusling | Dónal Leech | Conan Mercer | Abby L. Jones | J. Rusling | D. Leech | C. Mercer | Abby L. Jones
[1] James F Rusling,et al. Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification. , 2009, ACS nano.
[2] J. Rusling,et al. On-line protein capture on magnetic beads for ultrasensitive microfluidic immunoassays of cancer biomarkers. , 2014, Biosensors & bioelectronics.
[3] S. Hanash,et al. Mining the plasma proteome for cancer biomarkers , 2008, Nature.
[4] M. Stampfer,et al. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[5] R. Zengerle,et al. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. , 2010, Chemical Society reviews.
[6] W. Benedict,et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.
[7] D. Leech,et al. Inexpensive Miniature Programmable Magnetic Stirrer from Reconfigured Computer Parts. , 2017 .
[8] Albert Folch,et al. 3D-printed microfluidic automation. , 2015, Lab on a chip.
[9] D. Leech,et al. Cost-Effective Wireless Microcontroller for Internet Connectivity of Open-Source Chemical Devices , 2018, Journal of Chemical Education.
[10] W. Isaacs,et al. GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus , 2008, The Prostate.
[11] Damith E W Patabadige,et al. Micro Total Analysis Systems: Fundamental Advances and Applications. , 2016, Analytical chemistry.
[12] M. I. Hassan,et al. Structural Model of Human PSA: A Target for Prostate Cancer Therapy , 2007, Chemical biology & drug design.
[13] James F Rusling,et al. Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics. , 2013, Analytical chemistry.
[14] Timothy D. Veenstra,et al. Proteomic patterns: their potential for disease diagnosis , 2005, Molecular and Cellular Endocrinology.
[15] G. Whitesides. The origins and the future of microfluidics , 2006, Nature.
[16] S. Varambally,et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. , 2010, Neoplasia.
[17] James F. Rusling,et al. Rapid Microfluidic Immunoassays of Cancer Biomarker Proteins Using Disposable Inkjet-Printed Gold Nanoparticle Arrays , 2013, ChemistryOpen.
[18] Jinke Li,et al. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis. , 2013, Gynecologic oncology.
[19] James F Rusling,et al. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. , 2010, The Analyst.
[20] N. Morgan,et al. Electrochemical immunosensors for detection of cancer protein biomarkers. , 2012, ACS nano.
[21] J. Du,et al. Association between CD14 Promoter -159C/T Polymorphism and the Risk of Sepsis and Mortality: A Systematic Review and Meta-Analysis , 2013, PloS one.
[22] J. Gu,et al. Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients. , 2013, Carcinogenesis.
[23] J. W. Findlay,et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. , 2000, Journal of pharmaceutical and biomedical analysis.
[24] B. Lokeshwar,et al. Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence? , 2006, Urologic oncology.
[25] Andrew J. Vickers,et al. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring , 2008, Nature Reviews Cancer.
[26] K. Bensalah,et al. New circulating biomarkers for prostate cancer , 2008, Prostate Cancer and Prostatic Diseases.
[27] James F Rusling,et al. Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. , 2012, Analytical chemistry.
[28] C. Bonorino,et al. CD14 Expression in the First 24h of Sepsis: Effect of −260C>T CD14 SNP , 2008, Immunological investigations.
[29] Ali K Yetisen,et al. Commercialization of microfluidic devices. , 2014, Trends in biotechnology.